Skip to main content
CDC Website

Surveillance

Global tuberculosis report 2023

WHO has published a global TB report every year since 1997. The main aim of the report is to provide a comprehensive and up-to-date assessment of the TB epidemic, and of progress in prevention, diagnosis and treatment of the disease at global, regional and country levels. This report is updated annually.

Multidisciplinary Studies of HIV/AIDS and Aging (R21 Clinical Trial Optional)

This NOFO invites applications at the intersection of HIV and aging by proposing research that aims to meet the following objectives: 1) Improve the understanding of biological, clinical, and socio-behavioral aspects of aging through the lens of HIV infection and its treatment; and 2) Improve approaches for testing, preventing, and treating HIV infection, and managing HIV-related comorbidities, co-infections, and complications in different populations and cultural settings by applying current aging science approaches.

Reported Tuberculosis in the United States, 2022

This 2022 edition of Reported Tuberculosis in the United States describes information on TB disease reported to the CDC since 1993. This year’s report emphasizes TB disease cases counted by reporting areas in 2022 and the ongoing effects of the COVID-19 pandemic on TB disease surveillance.

Reported Tuberculosis in the United States, 2020

This 2020 edition of Reported Tuberculosis in the United States reflects a uniquely challenging year for public health and the TB community. The report describes information on cases of tuberculosis (TB) disease reported to CDC since 1993. This year’s report emphasizes cases counted by the reporting areas in 2020 and the effects of the COVID-19 pandemic on TB surveillance.

Pulmonary Outcomes and Sequelae after Treatment-TB (POST-TB) (R01 Clinical Trial Optional)

The purpose of this Funding Opportunity Announcement (FOA) is to support applications for epidemiological and observational research projects on the long-term cardiopulmonary sequelae following treatment for tuberculosis (TB). Investigators should propose additional testing and data collection in existing cohorts of adult and/or pediatric TB participants to better characterize and understand adverse outcomes and morbidity associated with TB disease post treatment in individuals with and without HIV infection.

HIV Data Protection Landscape For EHE Jurisdictions

The map summarizes state laws and regulations that addresses authorities and protections related to the health departments HIV surveillance data release, which is in response to data requests from courts, prosecutors, and law enforcement agencies. It also reflects laws in Priority Jurisdictions included in Phase I of the federal “Ending the HIV Epidemic: Plan for America” (EHE) initiative, which aims to end the HIV epidemic in the United States by 2030.

Innovation Health Practices

The United States Agency for International Development (USAID) is issuing this Broad Agency Announcement (BAA) to seek participants to co-create, co-design, co-invest, and collaborate on creating, piloting, and scaling innovative research and development interventions utilizing innovative health practices to help reduce disease and mortality rates worldwide.